Hypertrophic cardiomyopathy. Clinical spectrum and treatment.
about
Cardiomyopathy classification: ongoing debate in the genomics eraExpression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypesDouble heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathyMedical therapy versus interventional therapy in hypertropic obstructive cardiomyopathyQRS fragmentation: its role in sherlocking the arrhythmogenic heartEchocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathyDiagnosis and management of hypertrophic cardiomyopathyClinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathyClinical and Mechanistic Insights Into theĀ Genetics of CardiomyopathyElectrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy miceTwo-dimensional strain profiles in patients with physiological and pathological hypertrophy and preserved left ventricular systolic function: a comparative analyses.Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm formation in a single family: case report.Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure.Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy.Newer indications for permanent pacemakers.Medical treatment of hypertrophic cardiomyopathy.Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients.Approach to Hypertrophic Cardiomyopathy.Hypertrophic Cardiomyopathy: Prevalence, Hypertrophy Patterns, and Their Clinical and ECG Findings in a Hospital at Qatar.Fragmented QRS as a predictor of arrhythmic events in patients with hypertrophic obstructive cardiomyopathy.The Brockenbrough-Braunwald-Morrow sign.Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: From Experiment to Standard of CareHypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death.[Clinical picture and therapy of hypertrophic cardiomyopathy]Visualization of transcoronary ablation of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: a comparison between cardiac MRI, invasive measurements and echocardiography.Chest pain in children.A transgenic rabbit model for human hypertrophic cardiomyopathy.Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy: infants, children, and adolescents.In hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thickness.Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy.Systolic compression of epicardial coronary and intramural arteries in children with hypertrophic cardiomyopathy.Left ventricular filling pressure assessed by exercise TDI was correlated with early HFNEF in patients with non-obstructive hypertrophic cardiomyopathyHypertrophic cardiomyopathy: a reviewNon-coronary percutaneous interventionPercutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.Survival and clinical behavior of hypertrophic cardiomyopathy in a latin american cohort in contrast to cohorts from the developed world.Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experienceDanon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey.
P2860
Q21284968-0B202F59-71BD-494D-84B0-D10255E7DE78Q24657150-193C8F89-61E8-4B9C-B4DE-B85F2493B898Q24681653-D282D96B-47AA-4494-8A44-71FE91E63F46Q24792735-1FF8DCB6-449A-44A1-999F-C7A544834A4BQ26741049-913F7997-1C73-4D85-8E4D-BD79EBD033A1Q26741587-42255FFC-34F5-41D2-B045-6CFCB815B08AQ26773621-288F7A73-6117-4108-BBC0-C423674E230EQ26999424-1D19CD78-4D4A-4079-B774-0A30F82551CAQ28075470-040785EC-271E-461A-9C10-58BCB7D7511DQ28592635-9C82B917-19DD-404A-8201-63F0C5978C66Q30464356-9A38B127-79CE-4FDE-976C-BDD0431A150DQ30484558-E476B0C8-EB5B-43CB-B970-269F8FFEE2E9Q30488408-5995EC26-DF76-4560-981A-4E693A888B1AQ31096652-B982F495-DCD4-4572-A826-E429824635F0Q31934937-FA2A136E-A58E-4A7C-A358-E9F02B75893DQ33145492-06919863-D9B0-44E6-AFC2-20B5F22A0A86Q33145754-6320B93E-8BFC-49F5-B614-8B973E95A7E3Q33151393-01A5E541-EC0D-4FB6-830B-6AE3C55D6B1AQ33151971-5E2406F7-7FCE-4DBF-8F14-7E577C18FD85Q33161280-03A6AC33-CB64-453C-BAC5-5DE1CC607067Q33163246-AE518786-D4D3-4EDD-9554-05BB191044D1Q33164424-BC62E8CB-7A91-4111-A7B5-471119409683Q33166450-37ECA153-3430-4E8B-BD03-BB7670F7080BQ33175046-F375F504-D261-4548-869C-9EB5DAEAAC17Q33175633-B605E058-8091-4A1B-8CEB-B8C95621983FQ33876155-25FEE48D-32C5-4932-926E-EF3847D0D3B4Q33894937-5D64074E-84A9-4EC5-9705-DEF2D721EA9AQ33903354-8F7E819D-50F9-4C9C-AA29-DF6B6E9F8A5BQ34074592-A723475C-C2B8-40B1-B815-5BA783F36E76Q34244943-1A069481-4320-43C9-9D1A-84BA3E44E70CQ34364374-49D85FD1-5C91-4E8E-B46A-B9C0994984E5Q34441506-40C0A4C4-0451-4C94-AB8B-03D6012939A2Q34452081-69967380-B2E1-4E73-A2C5-BEC29A93E315Q34901113-FA0DE09A-FD76-40B1-965A-85D67B2FC7B0Q35024040-6AB3AFFD-8815-424E-B9BF-9E846F41E384Q35175556-DCC2A4AC-C78D-4968-B502-6B3BD79761E4Q35375206-4C3F73CB-04C2-4EB3-900F-8844EF9541DBQ35436364-3EB6C9D4-18C5-4577-8C1E-7BC4BEE499B7Q35438487-695B6800-79B1-4218-8310-2DC03A6DE1EEQ35582715-A179CC7E-4E84-41D1-BCDB-160BC0686B12
P2860
Hypertrophic cardiomyopathy. Clinical spectrum and treatment.
description
1995 nĆ® lÅ«n-bĆ»n
@nan
1995幓ć®č«ę
@ja
1995幓å¦ęÆęē«
@wuu
1995幓å¦ęÆęē«
@zh-cn
1995幓å¦ęÆęē«
@zh-hans
1995幓å¦ęÆęē«
@zh-my
1995幓å¦ęÆęē«
@zh-sg
1995幓åøč”ęē«
@yue
1995幓åøč”ęē«
@zh
1995幓åøč”ęē«
@zh-hant
name
Hypertrophic cardiomyopathy. Clinical spectrum and treatment.
@en
type
label
Hypertrophic cardiomyopathy. Clinical spectrum and treatment.
@en
prefLabel
Hypertrophic cardiomyopathy. Clinical spectrum and treatment.
@en
P2093
P356
P1433
P1476
Hypertrophic cardiomyopathy. Clinical spectrum and treatment.
@en
P2093
Kimball BP
Rakowski H
Williams WG
P304
P356
10.1161/01.CIR.92.7.1680
P407
P577
1995-10-01T00:00:00Z